Cargando…
A machine learning approach for identifying variables associated with risk of developing neutralizing antidrug antibodies to factor VIII
A key unmet need in the management of hemophilia A (HA) is the lack of clinically validated markers that are associated with the development of neutralizing antibodies to Factor VIII (FVIII) (commonly referred to as inhibitors). This study aimed to identify relevant biomarkers for FVIII inhibition u...
Autores principales: | Rawal, Atul, Kidchob, Christopher, Ou, Jiayi, Yogurtcu, Osman N., Yang, Hong, Sauna, Zuben E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220358/ https://www.ncbi.nlm.nih.gov/pubmed/37251488 http://dx.doi.org/10.1016/j.heliyon.2023.e16331 |
Ejemplares similares
-
The MHC Associated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicity
por: Jankowski, Wojciech, et al.
Publicado: (2023) -
SampPick: Selection of a Cohort of Subjects Matching a Population HLA Distribution
por: McGill, Joseph R., et al.
Publicado: (2019) -
Polymorphisms in the F8 Gene and MHC-II Variants as Risk Factors for the Development of Inhibitory Anti-Factor VIII Antibodies during the Treatment of Hemophilia A: A Computational Assessment
por: Pandey, Gouri Shankar, et al.
Publicado: (2013) -
Detection of Intracellular Factor VIII Protein in Peripheral Blood Mononuclear Cells by Flow Cytometry
por: Pandey, Gouri Shankar, et al.
Publicado: (2013) -
The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate
por: Mojtahed Poor, Sorwe, et al.
Publicado: (2023)